Introduction

In May 2026, Polycystic Ovary Syndrome (PCOS) was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a global consensus published in The Lancet. The previous name was widely criticized for being misleading, limiting healthcare and diagnosis, and contributing to stigma surrounding the condition.

More than Ovarian Disorder 

PMOS encompasses diverse endocrine, metabolic, reproductive, psychological, and dermatological features. The former name reflected only one organ and failed to capture the disorder’s multisystem nature. Experts argued that the term “PCOS” incorrectly centered ovarian cysts as the defining feature, despite many patients never developing them.

Statistics 

For decades, millions of women have battled with PMOS, formerly known as PCOS. Roughly 1 in 8 women are affected worldwide, more than 170 million women during their reproductive years, with nearly 70% remaining undiagnosed, according to global health experts.

Problems with the Old Name 

The name change is significant because it finally reflects the true nature of the condition. PMOS extends far beyond physical symptoms. It affects women physically, mentally, emotionally, and metabolically all at once. It is not simply a fertility disorder, as it was often previously portrayed. For years, the term PCOS narrowed medical focus to the ovaries, resulting in limited, symptom-based treatment approaches. This misunderstanding often overlooked the condition’s broader hormonal and metabolic impacts. The new name shifts attention toward the entire body, recognizing the complex relationship between metabolism, hormones, inflammation, insulin resistance, ovulation, mental health, and lifestyle factors.

Why PMOS Matters 

This redefinition broadens medical understanding and encourages more precise diagnosis, individualized treatment, and holistic healthcare. It also improves awareness of the female body and the level of care required to properly support women living with the condition.

Broader Changes Happening 

Coordinated implementation is already underway across health systems, research institutions, funding bodies, medical education, clinical guidelines, and international disease classification systems, including ICD coding. A global transition period and ongoing evaluation process have also been introduced to support the change.

Conclusion 

More than a medical update, this name change represents validation for millions of women who were misdiagnosed, dismissed, misunderstood, or inadequately treated for years. It acknowledges that they are more than their symptoms and serves as a renewed source of hope for those still fighting to be heard.

Social Media: https://www.facebook.com/profile.php?id=61550236114465